Literature DB >> 2316002

Cefotaxime-induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism.

I A Shulman1, P A Arndt, W McGehee, G Garratty.   

Abstract

Until recently, all cephalosporin-induced immune hemolytic anemias appeared to react by a "penicillin-type" drug adsorption mechanism, and hemolysis was extravascular. In 1987 and 1988, the first two cases of cephalosporin-induced immune hemolytic anemia with intravascular hemolysis associated with a so-called immune complex mechanism were reported. This report describes a case of extravascular hemolysis due to a third-generation cephalosporin, cefotaxime, which, to the authors' knowledge, is the first to show in vitro characteristics of both the drug adsorption and the so-called immune complex mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316002     DOI: 10.1046/j.1537-2995.1990.30390194351.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

Review 1.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 2.  Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

Authors:  R N Brogden; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 3.  Adverse effects of newer cephalosporins. An update.

Authors:  J W Thompson; R F Jacobs
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

4.  When a transfusion in an emergency service is not really urgent: hyperhaemolysis syndrome in a child with sickle cell disease.

Authors:  Sara Chinchilla Langeber; Marta Pilar Osuna Marco; María Benedit; Áurea Cervera Bravo
Journal:  BMJ Case Rep       Date:  2018-03-27

5.  Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.

Authors:  Yuanjun Wu; Yong Wu; Yong Yang; Baochan Chen; Jianqun Li; Ganping Guo; Fu Xiong
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.